Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 198 participants.

Also called NCT06737757

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 198 participants (planned count) (from the registry)
Sponsor
Suzhou Hearthill Medical Technology Co.,LTD (from the registry)
Registry
  • NCT NCT06737757
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT06737757. Randomized; single masking; primary purpose treatment. Start 2024-12 (anticipated); primary completion 2026-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease
Condition
Aortic Valve Stenosis
Condition
Aortic Valve Disease
Condition
Aortic Valve Regurgitation
Intervention (Device)
Artificial polymer heart valves
Intervention (Device)
Bovine pericardial aortic valve
Lead sponsor
Suzhou Hearthill Medical Technology Co.,LTD (class: industry)

Record details

Record id
cardio:ct-nct06737757
Content hash
1f024e05608fe94fd449cc4fe35b55a2f3ab34dff32d11f3fd5dea86de28e9e2